211 related articles for article (PubMed ID: 11895915)
21. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival.
Quiros RM; Rao G; Plate J; Harris JE; Brunn GJ; Platt JL; Gattuso P; Prinz RA; Xu X
Cancer; 2006 Feb; 106(3):532-40. PubMed ID: 16388520
[TBL] [Abstract][Full Text] [Related]
22. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
[TBL] [Abstract][Full Text] [Related]
23. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
24. High serum levels of DUPAN2 antigen and CA19-9 in pancreatic cancer: correlation with immunocytochemical localization of antigens in cancer cells.
Suzuki Y; Ichihara T; Nakao A; Sakamoto J; Takagi H; Nagura H
Hepatogastroenterology; 1988 Jun; 35(3):128-35. PubMed ID: 3042577
[TBL] [Abstract][Full Text] [Related]
25. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
[TBL] [Abstract][Full Text] [Related]
26. Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer.
Yao J; Zhang LL; Huang XM; Li WY; Gao SG
World J Gastroenterol; 2017 Jun; 23(21):3907-3914. PubMed ID: 28638231
[TBL] [Abstract][Full Text] [Related]
27. Increased growth factor expression after hepatic and pancreatic resection.
Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
[TBL] [Abstract][Full Text] [Related]
28. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
29. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of the expression of MUC4 mRNA in peripheral blood mononuclear cells of pancreatic cancer patients].
Li XH; Xiong JX; Wang CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):624-7. PubMed ID: 16274046
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
32. Expression of proteinase-activated receptor-2 in human pancreatic cancer: a possible relation to cancer invasion and induction of fibrosis.
Ikeda O; Egami H; Ishiko T; Ishikawa S; Kamohara H; Hidaka H; Mita S; Ogawa M
Int J Oncol; 2003 Feb; 22(2):295-300. PubMed ID: 12527925
[TBL] [Abstract][Full Text] [Related]
33. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
[TBL] [Abstract][Full Text] [Related]
34. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
35. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.
Monti P; Leone BE; Marchesi F; Balzano G; Zerbi A; Scaltrini F; Pasquali C; Calori G; Pessi F; Sperti C; Di Carlo V; Allavena P; Piemonti L
Cancer Res; 2003 Nov; 63(21):7451-61. PubMed ID: 14612545
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.
Link BC; Reichelt U; Schreiber M; Kaifi JT; Wachowiak R; Bogoevski D; Bubenheim M; Cataldegirmen G; Gawad KA; Issa R; Koops S; Izbicki JR; Yekebas EF
Ann Surg Oncol; 2007 Sep; 14(9):2591-9. PubMed ID: 17549567
[TBL] [Abstract][Full Text] [Related]
37. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers.
Lee CS; Charalambous D
Zentralbl Pathol; 1994 Aug; 140(3):271-5. PubMed ID: 7947635
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues.
Garver RI; Chan CS; Milner PG
Am J Respir Cell Mol Biol; 1993 Nov; 9(5):463-6. PubMed ID: 8217186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
